Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms
Alzheimer's & Dementia · 2025-04 · 21 (4)
DOI: 10.1002/alz.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.04.2025. Verfasst von Jeong Eun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health & Community Systems, University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Cognitive Dysfunction, Psychological Distress, Disclosure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION We examined differences in emotional distress following amyloid positron emission tomography (PET) results disclosure across the cognitive spectrum, including individuals who are cognitively unimpaired, with mild cognitive impairment (MCI), and dementia. METHODS Seventy‐five participants from the University of Pittsburgh Alzheimer's Disease Research Center who completed baseline PET and an initial follow‐up call were included in the analysis. Multiple linear regression was employed to examine differences in distress among diagnostic groups, as measured by Impact of Genetic Testing for Alzheimer's Disease (IGT‐AD) adapted for amyloid PET. RESULTS Regression analysis revealed significant associations between diagnostic categories and emotional distress post‐disclosure. Pairwise comparisons indicated that those with normal cognition experienced significantly lower distress compared to MCI and dementia groups, even after controlling for amyloid status. DISCUSSION Emotional distress following amyloid PET disclosure is significantly higher in cognitively symptomatic individuals compared to the asymptomatic, highlighting the need for tailored counseling and support to address the complex psychological effects of disclosure. Highlights Emotional distress was compared across cognitive categories outside trial settings Cognitively unimpaired individuals had significantly lower distress than impaired No significant difference in distress was found between MCI and dementia groups Depression and anxiety did not differ significantly across diagnostic categories
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health & Community Systems, University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA.
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- University of Pittsburgh Alzheimer's Disease Research Center, Pittsburgh, Pennsylvania, USA.
- Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Jeong Eun Kim
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kim, J. E., Ren, D., Cohen, A. D., Lopez, O. L., & Lingler, J. H. (2025). Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms. Alzheimer's & Dementia, 21(4). https://doi.org/10.1002/alz.70121
Vancouver
Kim JE, Ren D, Cohen AD, Lopez OL, Lingler JH. Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms. Alzheimer's & Dementia. 2025;21(4). doi:10.1002/alz.70121
BibTeX
@article{Kim2025,
author = {Kim, Jeong Eun and Ren, Dianxu and Cohen, Ann D and Lopez, Oscar L and Lingler, Jennifer H},
title = {Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {4},
doi = {10.1002/alz.70121}
}
EUVIMED